CRLCHARLES RIVER LABORATORIES ...

NYSE criver.com


$ 227.56 $ -2.54 (-1.1 %)    

Thursday, 18-Apr-2024 15:59:58 EDT
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 227.55
$ 226.50
$ 0.00 x 0
$ 0.00 x 0
$ 226.17 - $ 233.36
$ 161.65 - $ 275.00
707,817
na
11.71B
$ 1.35
$ 24.67
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-14-2024 12-30-2023 10-K
2 11-08-2023 09-30-2023 10-Q
3 08-09-2023 07-01-2023 10-Q
4 05-11-2023 04-01-2023 10-Q
5 02-22-2023 12-31-2022 10-K
6 11-02-2022 09-24-2022 10-Q
7 08-03-2022 06-25-2022 10-Q
8 05-04-2022 03-26-2022 10-Q
9 02-16-2022 12-25-2021 10-K
10 11-03-2021 09-25-2021 10-Q
11 08-04-2021 06-26-2021 10-Q
12 05-04-2021 03-27-2021 10-Q
13 02-17-2021 12-26-2020 10-K
14 11-09-2020 09-26-2020 10-Q
15 10-29-2020 09-26-2020 10-Q
16 08-05-2020 06-27-2020 10-Q
17 05-07-2020 03-28-2020 10-Q
18 02-11-2020 12-28-2019 10-K
19 11-06-2019 09-28-2019 10-Q
20 07-31-2019 06-29-2019 10-Q
21 05-07-2019 03-30-2019 10-Q
22 02-13-2019 12-29-2018 10-K
23 11-07-2018 09-29-2018 10-Q
24 08-08-2018 06-30-2018 10-Q
25 05-10-2018 03-31-2018 10-Q
26 02-13-2018 12-30-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-09-2017 07-01-2017 10-Q
29 05-10-2017 04-01-2017 10-Q
30 02-14-2017 12-31-2016 10-K
31 11-02-2016 09-24-2016 10-Q
32 08-03-2016 06-25-2016 10-Q
33 05-04-2016 03-26-2016 10-Q
34 02-12-2016 12-26-2015 10-K
35 11-04-2015 09-26-2015 10-Q
36 07-30-2015 06-27-2015 10-Q
37 04-30-2015 03-28-2015 10-Q
38 02-17-2015 12-27-2014 10-K
39 10-30-2014 09-27-2014 10-Q
40 08-07-2014 06-28-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 charles-river-to-perform-plasmid-production-for-ship-of-theseus

GMP grade plasmid DNA to serve as a direct therapeutic targeting various indicationsCharles River Laboratories International, I...

 argus-research-maintains-buy-on-charles-river-raises-price-target-to-290

Argus Research analyst David Toung maintains Charles River (NYSE:CRL) with a Buy and raises the price target from $200 to $290.

 charles-river-and-navega-therapeutics-announce-comprehensive-gene-therapy-manufacturing-collaboration

Next-generation AAV gene therapy to target debilitating pain disorders Charles River Laboratories International, Inc. (NYSE:CR...

 wheeler-bio-taps-charles-river-to-offer-portable-cmc-to-discovery-clients-to-accelerate-their-journey-to-first-in-human-use

Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today a new strategic agreeme...

 charles-river-and-wheeler-bio-complete-agreement-to-accelerate-the-journey-from-discovery-and-cmc-development-to-manufacturing

 Charles River Laboratories International, Inc. (NYSE:CRL) today announced a strategic agreement with Wheeler Bio, Inc., an ant...

 charles-river-collaborates-with-pluristyx-expanding-its-portfolio-of-human-pluripotent-stem-cells

The addition of ES cells and iPSCs will enhance Charles River's portfolio of powerful research tools supporting acceleratio...

 guggenheim-downgrades-charles-river-to-neutral

Guggenheim analyst Sandy Draper downgrades Charles River (NYSE:CRL) from Buy to Neutral.

 stocks-rebound-as-investor-focus-shifts-to-earnings-bitcoin-tops-1-trillion-value-whats-driving-markets-wednesday

The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation ...

 charles-river-laboratories-stock-surges-on-upbeat-annual-outlook-but-this-analyst-is-concerned

Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance...

 why-sony-shares-are-trading-lower-by-around-6-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financi...

 charles-river-laboratories-international-posts-upbeat-results-joins-robinhood-zillow-tower-semiconductor-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

 charles-river-q4-adjusted-eps-246-beats-240-estimate-sales-101b-beat-99125m-estimate

Charles River (NYSE:CRL) reported quarterly earnings of $2.46 per share which beat the analyst consensus estimate of $2.40 by 2...

 earnings-scheduled-for-february-14-2024

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION